僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Lanadelumab （SHP643） is a humanized IgG1 monoclonal antibody against plasma kallikrein （pKal） with an Ki value of 0.12 nM. Lanadelumab inhibits both free and HMWK （high molecular weight kininogen）-bound pKal. Lanadelumab has the potential for the research of hereditary angioedema